UBS Group’s Roth CH Acquisition V Co. Common Stock ROCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-486
Closed -$5.35K 10295
2024
Q2
$5.35K Buy
+486
New +$5.31K ﹤0.01% 8007
2024
Q1
Sell
-2,000
Closed -$21.3K 10203
2023
Q4
$21.3K Buy
+2,000
New +$21.2K ﹤0.01% 7071
2023
Q1
Sell
-408
Closed -$4.13K 10651
2022
Q4
$4.13K Sell
408
-1,100
-73% -$11K ﹤0.01% 9382
2022
Q3
$15K Sell
1,508
-723
-32% -$7.16K ﹤0.01% 7840
2022
Q2
$22K Buy
2,231
+1,540
+223% +$15.2K ﹤0.01% 6780
2022
Q1
$7K Buy
+691
New +$6.79K ﹤0.01% 8864

Other funds holding ROCL

UBS Group's ROCL Position: Q3 2024 in Review

UBS Group sold out of Roth CH Acquisition V Co. Common Stock (ROCL) in Q3 2024, closing a stake of 486 shares — an estimated $5.35K sold.

UBS Group first reported a position in ROCL in Q1 2022 and held it in 6 quarters. The position peaked at $22K in Q2 2022. 11 funds tracked by Wall St. Rank hold ROCL as of Q3 2024.

  • UBS Group reported no remaining Roth CH Acquisition V Co. Common Stock position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 486 Roth CH Acquisition V Co. Common Stock shares in Q3 2024, an estimated $5.35K.
  • UBS Group first reported a position in Roth CH Acquisition V Co. Common Stock in Q1 2022 and held it in 6 quarters.
  • UBS Group's Roth CH Acquisition V Co. Common Stock position peaked at $22K in Q2 2022.
  • 11 funds tracked by Wall St. Rank held Roth CH Acquisition V Co. Common Stock as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.